Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

KRX:019170 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41,175	41,986	43,800	41,691	27,637	55,803
Short-Term Investments	13,804	14,475	16,245	14,226	64,599	122,872
Trading Asset Securities	-	-	535.69	-	465.97	11,965
Cash & Short-Term Investments	54,979	56,461	60,581	55,917	92,702	190,639
Cash Growth	-5.27%	-6.80%	8.34%	-39.68%	-51.37%	188.14%
Accounts Receivable	66,986	70,163	73,661	82,289	81,865	88,671
Other Receivables	3,507	2,155	8,083	8,081	7,860	7,908
Receivables	70,697	72,523	81,945	90,576	89,925	96,779
Inventory	56,573	55,382	53,923	46,895	47,707	49,088
Prepaid Expenses	2,196	2,757	766.58	1,008	900.48	895.93
Other Current Assets	2,144	2,199	1,719	2,147	1,764	1,174
Total Current Assets	186,590	189,321	198,935	196,542	232,997	338,577
Property, Plant & Equipment	113,919	115,398	118,638	113,760	116,884	124,177
Long-Term Investments	24,989	24,896	21,107	29,336	28,571	14,876
Other Intangible Assets	4,881	5,006	5,769	6,931	8,971	8,062
Long-Term Deferred Tax Assets	2,059	2,826	475.25	6,628	9,086	5,394
Other Long-Term Assets	4,471	4,633	5,159	8,339	1,841	1,829
Total Assets	336,921	342,093	350,084	361,536	398,350	492,915
Accounts Payable	10,831	9,998	8,941	11,428	12,060	8,789
Accrued Expenses	5,937	9,021	13,856	7,300	7,057	4,953
Short-Term Debt	45,500	47,305	45,000	-	248.11	150.17
Current Portion of Long-Term Debt	1,400	1,400	-	-	-	-
Current Portion of Leases	918.96	951.49	932.48	1,487	719.94	1,059
Current Income Taxes Payable	38.43	112.5	118.11	-	133.02	59,467
Other Current Liabilities	7,492	7,056	7,537	6,952	8,332	8,919
Total Current Liabilities	72,117	75,844	76,385	27,167	28,550	83,337
Long-Term Debt	4,600	4,600	-	-	-	-
Long-Term Leases	330.58	340.84	218.96	441.51	212.67	575.85
Other Long-Term Liabilities	3,220	3,218	2,698	3,169	2,197	2,341
Total Liabilities	80,268	84,003	79,301	30,778	38,025	112,820
Common Stock	27,592	27,592	27,592	27,592	27,592	27,592
Additional Paid-In Capital	213,592	213,592	213,592	213,592	213,592	213,592
Retained Earnings	37,659	38,943	55,331	115,830	144,925	162,361
Treasury Stock	-8,734	-8,734	-8,734	-8,734	-8,734	-8,734
Comprehensive Income & Other	-14,748	-14,573	-18,196	-18,673	-18,118	-15,675
Total Common Equity	255,362	256,821	269,586	329,607	359,257	379,137
Minority Interest	1,292	1,269	1,196	1,151	1,067	958.76
Shareholders' Equity	256,653	258,090	270,782	330,758	360,324	380,095
Total Liabilities & Equity	336,921	342,093	350,084	361,536	398,350	492,915
Total Debt	52,750	54,597	46,151	1,928	1,181	1,785
Net Cash (Debt)	2,230	1,864	14,430	53,988	91,521	188,854
Net Cash Growth	-81.51%	-87.08%	-73.27%	-41.01%	-51.54%	-
Net Cash Per Share	43.82	36.36	281.49	1053.18	1785.35	3752.42
Filing Date Shares Outstanding	51.26	51.26	49.27	49.27	49.27	49.27
Total Common Shares Outstanding	51.26	51.26	51.26	51.26	51.26	51.26
Working Capital	114,472	113,477	122,550	169,375	204,447	255,240
Book Value Per Share	4981.47	5009.93	5258.95	6429.82	7008.22	7396.02
Tangible Book Value	250,480	251,814	263,817	322,676	350,286	371,075
Tangible Book Value Per Share	4886.25	4912.27	5146.41	6294.62	6833.22	7238.75
Land	15,976	15,976	15,976	15,976	15,976	15,976
Buildings	119,537	121,660	120,117	121,946	123,266	120,809
Machinery	104,108	112,867	103,969	104,000	104,224	98,806
Construction In Progress	1,048	1,124	5,426	4,231	329.3	4,974

Source: S&P Global Market Intelligence. Standard template. Financial Sources.